How Genalyte Is Turning Same-Visit Diagnostics Into Lifesaving Decisions

Nearly 70% of medical decisions depend on laboratory tests, yet most outpatient lab work still requires patients to leave the clinic, travel to a separate draw station, and wait days for results, then wait again for provider interpretation. These delays create critical gaps in care:

25% of patients never complete their labs, leading to missed or delayed diagnoses
Central laboratory turnaround times average 2 to 3 days, postponing treatment decisions
5% of outpatient samples sent to central labs contain errors that can alter diagnoses or cause serious harm

For conditions such as diabetes, sepsis, electrolyte imbalance, and anemia, delays of even a few hours can dramatically increase risk. Timely diagnostics are not a convenience, they are often the difference between early intervention and life threatening escalation.

Genalyte’s point of care platform, The Merlin, brings comprehensive chemistry, hematology, and immunoassay testing directly into the clinic, delivering actionable results in under 30 minutes. This enables same-visit diagnosis and treatment, closing gaps in care that routinely exist in traditional outpatient workflows.

A Routine Visit That Wasn’t

A 74 year old man with no significant medical history came in to see his primary care provider in Texas reporting general malaise and fatigue. He thought he might be coming down with a mild cold or flu and was hoping for antibiotics. Otherwise, he appeared well and showed no obvious signs of concern. In fact, he even mentioned he was planning to play golf later that day. The physical exam revealed no obvious red flags that would typically justify urgent escalation of care.

Read the full article here.

‍